Freenome is working with pharmaceutical companies, integrated health systems,
and academic institutions to use its AI genomics platform to address cancer’s most
Together, we're proud to be at the forefront in developing the next generation of
genomic screening tools and precision oncology therapies.
Novel biomarker discovery
New target discovery
Resistance pathway analysis
Response prediction for immuno-oncology and epigenetic modiﬁer